methylglucamine iodoxamate: RN given refers to meglumine salt (2:1) [MeSH]
| ID Source | ID |
|---|---|
| PubMed CID | 23620848 |
| CHEMBL ID | 4594231 |
| MeSH ID | M0093284 |
| Synonym |
|---|
| meglumine iodoxamate |
| benzoic acid, 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodo-, compound with 1-deoxy-1-(methylamino)-d-glucitol (1:2) |
| d-glucitol, 1-deoxy-1-(methylamino)-, 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodobenzoate) (2:1) (salt) |
| 3,3'-(ethylenebis(oxyethyleneoxyethylenecarbonylimino))bis(2,4,6-triiodobenzoic acid) compound with 1-deoxy-1-(methylamino)-d-glucitol (1:2) |
| cholovue |
| iodoxamate meglumine [usan:ban] |
| iodoxamate meglumine |
| einecs 257-398-6 |
| methylglucamine iodoxamate |
| iodoxamic acid meglumine salt |
| cholovue (tn) |
| iodoxamate meglumine (usan) |
| 51764-33-1 |
| D04573 |
| cix5g6j9r1 , |
| unii-cix5g6j9r1 |
| iodoxamate meglumine [who-dd] |
| iodoxamate meglumine [orange book] |
| meglumine iodoxamate [mart.] |
| iodoxamate meglumine [usan] |
| 3-[3-[2-[2-[2-[3-(3-carboxy-2,4,6-triiodoanilino)-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol |
| Q27275487 |
| CHEMBL4594231 |
| DTXSID301027216 |
| meglumine iodoxamate (mart.) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 3 (33.33%) | 5.53% |
| Reviews | 1 (11.11%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (55.56%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| metrizoate | monocarboxylic acid | radioopaque medium | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 | |
| iodipamide | benzoic acids; organoiodine compound; secondary carboxamide | radioopaque medium | 1981 | 1982 | 42.6 | high | 3 | 5 | 0 | 0 | 0 | 0 | |
| ioxaglate | benzenedicarboxamide; benzoic acids; organoiodine compound | radioopaque medium | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 | |
| methylglucamine metrizoate | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 | |||
| b 10610 | organic molecular entity | 1981 | 1983 | 42.3 | high | 3 | 6 | 0 | 0 | 0 | 0 | ||
| meglumine iotroxinate | 1981 | 1982 | 42.5 | high | 3 | 4 | 0 | 0 | 0 | 0 | |||
| iothalamate meglumine | amidobenzoic acid | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 | ||
| meglumine ioxithalamate | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abnormalities, Digestive System | 0 | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Acute Liver Injury, Drug-Induced | 0 | 1981 | 1981 | 43.0 | low | 1 | 1 | 0 | 0 | 0 | 0 | |
| Bile Duct Cysts | 0 | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Bile Duct Obstruction | 0 | 1981 | 1981 | 43.0 | low | 0 | 1 | 0 | 0 | 0 | 0 | |
| Biliary Calculi | 0 | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
| Chemical and Drug Induced Liver Injury | 0 | 1981 | 1981 | 43.0 | low | 1 | 1 | 0 | 0 | 0 | 0 | |
| Cholelithiasis | 0 | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
| Cholestasis | 0 | 1981 | 1981 | 43.0 | low | 0 | 1 | 0 | 0 | 0 | 0 | |
| Complication, Postoperative | 0 | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
| Eosinophilia | 0 | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 | |
| Eosinophilia, Tropical | 0 | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 | |
| Gallstone Disease | 0 | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
| Gallstones | 0 | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
| Liver Diseases | 0 | 1981 | 1981 | 43.0 | low | 0 | 1 | 0 | 0 | 0 | 0 | |
| Liver Dysfunction | 0 | 1981 | 1981 | 43.0 | low | 0 | 1 | 0 | 0 | 0 | 0 | |
| Postoperative Complications | 0 | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
| Sensitivity and Specificity | 0 | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Article | Year |
|---|---|
| Eosinophilia caused by iodinated radiographic contrast media. Clinical radiology, , Volume: 34, Issue:6 | 1983 |